Key points are not available for this paper at this time.
Design
Discussion
The phenomenon of revertant dystrophin expression in muscular dystrophy highlights complex mechanisms of alternative splicing that could inform future therapeutic strategies.
A brief discussion about skeletal muscle, aberrant expression of dystrophin from null mutations of the gene, potential explanations as to why this occurs, and how understanding this could be useful for potential therapies in the future.
No takes yet. Share an insight, caveat, or question.
Terence A. Partridge (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: